AR221717A1 - Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona - Google Patents

Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona

Info

Publication number
AR221717A1
AR221717A1 AR275802A AR27580279A AR221717A1 AR 221717 A1 AR221717 A1 AR 221717A1 AR 275802 A AR275802 A AR 275802A AR 27580279 A AR27580279 A AR 27580279A AR 221717 A1 AR221717 A1 AR 221717A1
Authority
AR
Argentina
Prior art keywords
propionyloxi
butyryloxi
hidroxi
diona
pregnen
Prior art date
Application number
AR275802A
Other languages
English (en)
Spanish (es)
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of AR221717A1 publication Critical patent/AR221717A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AR275802A 1978-03-29 1979-03-14 Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona AR221717A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53036251A JPS6040439B2 (ja) 1978-03-29 1978-03-29 ヒドロコルチゾン誘導体

Publications (1)

Publication Number Publication Date
AR221717A1 true AR221717A1 (es) 1981-03-13

Family

ID=12464544

Family Applications (1)

Application Number Title Priority Date Filing Date
AR275802A AR221717A1 (es) 1978-03-29 1979-03-14 Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona

Country Status (11)

Country Link
US (1) US4290962A (fr)
JP (1) JPS6040439B2 (fr)
AR (1) AR221717A1 (fr)
CH (1) CH638227A5 (fr)
DE (1) DE2910899C2 (fr)
FR (1) FR2421180A1 (fr)
GB (1) GB2020291B (fr)
IT (1) IT1116531B (fr)
KE (1) KE3481A (fr)
MY (1) MY8500791A (fr)
SG (1) SG55584G (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2826257C3 (de) * 1978-06-15 1980-12-04 Beiersdorf Ag, 2000 Hamburg Hydrocortison-17,21-diester und Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie Hydrocortison -17-propionat als Zwischenprodukt
DE3169460D1 (en) * 1980-12-23 1985-04-25 Schering Ag 6-alpha-methyl hydrocortisone derivatives, their preparation and their utilization
DE3133081A1 (de) * 1981-08-18 1983-03-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung
JPS59137408A (ja) * 1983-01-27 1984-08-07 Taisho Pharmaceut Co Ltd 軟膏
AT389447B (de) * 1983-01-27 1989-12-11 Taisho Pharmaceutical Co Ltd Verfahren zur herstellung einer topischen steroidsalbe
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
JP4950660B2 (ja) * 2003-06-27 2012-06-13 エチコン、インコーポレイテッド 分娩後由来細胞を使用する眼組織の修復および再生
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
JP2007504123A (ja) * 2003-08-29 2007-03-01 ランバクシー ラボラトリーズ リミテッド Ｉｖ型ホスホジエステラーゼの阻害剤
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
PL1831356T3 (pl) 2004-12-23 2017-07-31 DePuy Synthes Products, Inc. Komórki poporodowe pochodzące z tkanki pępowinowej i sposoby ich wytwarzania i stosowania
WO2007031838A1 (fr) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
WO2007045980A1 (fr) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de la phosphodiesterase de type iv
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
PL1971681T3 (pl) 2005-12-16 2018-01-31 Depuy Synthes Products Inc Kompozycje oraz sposoby do hamowania niepożądanej odpowiedzi immunologicznej w przypadku transplantacji z brakiem zgodności tkankowej
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US20110021473A1 (en) * 2006-09-22 2011-01-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (fr) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibiteurs de phosphodiestérase
JP5670053B2 (ja) 2006-11-13 2015-02-18 エシコン・インコーポレイテッドＥｔｈｉｃｏｎ， Ｉｎｃｏｒｐｏｒａｔｅｄ マイクロキャリアを使用した、産褥由来の細胞の生体外での拡大
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
MX2009009793A (es) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (fr) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de type IV de la phosphodiestérase
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
ES2665883T3 (es) * 2008-12-19 2018-04-30 DePuy Synthes Products, Inc. Tratamiento de enfermedades y trastornos pulmonares y pulmonares
CN104356188A (zh) * 2014-10-23 2015-02-18 华中药业股份有限公司 一种丁酸氢化可的松的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH429716A (de) * 1961-06-24 1967-02-15 Vismara Francesco Spa Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden
GB1043347A (en) * 1963-05-10 1966-09-21 Glaxo Lab Ltd 17,21-orthoesters of steroids
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
US3422193A (en) * 1966-08-11 1969-01-14 Schering Corp 17-mono esters of corticoids
DE2144405A1 (de) * 1971-09-04 1973-03-08 Merck Patent Gmbh Verfahren zur herstellung von estern der pregnanreihe
DE2826257C3 (de) * 1978-06-15 1980-12-04 Beiersdorf Ag, 2000 Hamburg Hydrocortison-17,21-diester und Verfahren zu deren Herstellung, diese enthaltende Arzneimittel sowie Hydrocortison -17-propionat als Zwischenprodukt

Also Published As

Publication number Publication date
FR2421180A1 (fr) 1979-10-26
KE3481A (en) 1985-01-04
GB2020291A (en) 1979-11-14
CH638227A5 (fr) 1983-09-15
DE2910899A1 (de) 1979-10-11
FR2421180B1 (fr) 1982-10-22
IT7948501A0 (it) 1979-03-27
JPS6040439B2 (ja) 1985-09-11
DE2910899C2 (de) 1986-02-13
IT1116531B (it) 1986-02-10
MY8500791A (en) 1985-12-31
SG55584G (en) 1985-03-08
JPS54128560A (en) 1979-10-05
US4290962A (en) 1981-09-22
GB2020291B (en) 1982-10-06

Similar Documents

Publication Publication Date Title
AR221717A1 (es) Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona
ES486786A0 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos.
ES495376A0 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
ES512401A0 (es) "un procedimiento para preparar derivados de tetralina".
ES496441A0 (es) Un procedimiento para la preparacion de nuevos derivados transisomericos de 4-fenil-1,2,3,4- tetrahidro-1-naftalenamina.
ES476994A0 (es) Procedimiento para preparar perhalociclopropanocarboxilatos.
ES479988A0 (es) Un procedimiento para la preparacion de nuevos derivados - hete rociclicos.
ES486425A0 (es) Un procedimiento para preparar nuevas 4-arilpiperinas.
AR231308A1 (es) Un procedimiento para preparar 1-be-d-ribofuranosil-1,2,4-triazolcarboxamida rivavirina
ES491221A0 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
ES517459A0 (es) Un procedimiento para preparar un dentifrico estable.
ES481478A0 (es) Procedimiento para preparar o-metaliloxifenol.
ES490101A0 (es) Un procedimiento para obtener 2,6-diaminonebularinas
ES489127A0 (es) Un procedimiento para la preparacion de nuevos 1, 2, 4-tria-zoles.
MX5790E (es) Procedimiento para preparar 1,2,3-tiadiazol-5-il ureas
ES493798A0 (es) Un procedimiento para preparar 7-alcoxicarbonil-6,8-dime- til-4-hidroximetil-1-ftalazona
ES493760A0 (es) Un procedimiento para preparar benzoxazepinas.
ES508062A0 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES492115A0 (es) Un procedimiento para la preparacion de 10, 11-dihidro-5-h- dibenzo (a,d) ciclohepten -5,10-iminas
ES493497A0 (es) Un procedimiento para preparar 1,2-dihidro-2-oxo-5-(piridi- nil)nicotinonitrilo
ES487034A0 (es) Un procedimiento para la preparacion de nuevas penenias sus-tituidas.
ES527278A0 (es) Un procedimiento para obtener 2,5-anhidro-3,4,6-tri-o-acil-d-alonselenocarboxamida
ES493015A0 (es) Un procedimiento para la preparacion de octahidro-1h-pirro- lo-(2,3g)isoquinolinas
ES494226A0 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
AR226418A1 (es) Un procedimiento para preparar compuestos de 2,4-dicloro-piridina